Begin typing your search above and press return to search.
proflie-avatar
Login
exit_to_app
NEETs credibility must be restored
access_time 14 Jun 2024 11:33 AM GMT
May peace prevail in West Asia
access_time 13 Jun 2024 5:29 AM GMT
The scholar and the ignoramus
access_time 12 Jun 2024 8:08 AM GMT
Modi cabinet
access_time 11 Jun 2024 12:41 PM GMT
All of us are victims of war
access_time 10 Jun 2024 4:15 AM GMT
exit_to_app
Homechevron_rightIndiachevron_rightSC allows a relief to...

SC allows a relief to Patanjali by reserving contempt notice

text_fields
bookmark_border
SC allows a relief to Patanjali by reserving contempt notice
cancel

New Delhi: Baba Ramdev and Patanjali Ayurved’s Managing Director Acharya Balkrishna have been relieved from the contempt notice issued by the Supreme Court over the continued publication of misleading advertisements by the ayurvedic company, as the court reversed its verdict.

Dispensing Ramdev and Balkrishna’s personal appearance in further proceedings, a bench of Justices Hima Kohli and Ahsanuddin Amanullah allowed three-week time to Patanjali to file an affidavit regarding the withdrawal of the sale of banned products and their advertisements. It took note of the submission that the entire page of newspapers containing the public apology published by Patanjali has been placed on record.

Earlier, the top court had rejected the “unconditional and unqualified apology” tendered by Ramdev and Balkrishna and took strong exception over the violation of the undertaking given to the Supreme Court in November last year. Patanjali had earlier assured the Supreme Court that it would not make any casual statements claiming the medicinal efficacy of its products or advertise or brand them in violation of law and would not release any statement against any system of medicine to the media in any form.

The Indian Medical Association has sought action against Patanjali for violation of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 – which prohibits the advertisement of certain products for the treatment of specified diseases and disorders, including diabetes, heart diseases, high or low blood pressure and obesity.

Meanwhile, the Uttarakhand government, in an affidavit, apprised the apex court that its State Licencing Authority has granted permission to file a complaint against Divya Pharmacy and Patanjali Ayurved Ltd. for repeated violations of the drug advertisements law and suspended manufacturing licenses for 14 of their products.


Source: IANS

Show Full Article
TAGS:Supreme CourtPatanjaliIndia news
Next Story